SUMOylation of VEGFR2 regulates its intracellular trafficking and pathological angiogenesis.
SUMOylation of VEGFR2 regulates its intracellular trafficking and pathological angiogenesis.
复制标题
VEGFR2 的 SUMO 化调节其细胞内运输和病理性血管生成
DOI:
10.1038/s41467-018-05812-2
复制
发表时间:
2018-08-17
影响因子:
16.6
通讯作者:
Min W
中科院分区:
文献类型:
--
作者:
Zhou HJ;Xu Z;Wang Z;Zhang H;Zhuang ZW;Simons M;Min W
Regulation of VEGFR2 represents an important mechanism for the control of angiogenesis. VEGFR2 activity can be regulated by post-translational modifications such as ubiquitination and acetylation. However, whether VEGFR2 can be regulated by SUMOylation has not been investigated. Here we show that endothelial-specific deletion of the SUMO endopeptidase SENP1 reduces pathological angiogenesis and tissue repair during hindlimb ischemia, and VEGF-induced angiogenesis in the cornea, retina, and ear. SENP1-deficient endothelial cells show increased SUMOylation of VEGFR2 and impaired VEGFR2 signalling. SUMOylation at lysine 1270 retains VEGFR2 in the Golgi and reduces its surface expression, attenuating VEGFR2-dependent signalling. Moreover, we find that SENP1 is downregulated and VEGFR2 hyper-SUMOylated in diabetic settings and that expression of a non-SUMOylated form of VEGFR2 rescues angiogenic defects in diabetic mice. These results show that VEGFR2 is regulated by deSUMOylation during pathological angiogenesis, and propose SENP1 as a potential therapeutic target for the treatment of diabetes-associated angiogenesis.
登录
查看更多内容
影响因子:
15.9
作者:
He, Yun;Luo, Yan;Min, Wang
通讯作者:
Min, Wang
影响因子:
17.1
作者:
Eming SA;Martin P;Tomic-Canic M
通讯作者:
Tomic-Canic M
影响因子:
15.9
作者:
Pasula, Satish;Cai, Xiaofeng;Chen, Hong
通讯作者:
Chen, Hong
影响因子:
16.6
作者:
Lumpkin RJ;Gu H;Zhu Y;Leonard M;Ahmad AS;Clauser KR;Meyer JG;Bennett EJ;Komives EA
通讯作者:
Komives EA
影响因子:
11.8
作者:
Lanahan, Anthony A.;Hermans, Karlien;Claes, Filip;Kerley-Hamilton, Joanna S.;Zhuang, Zhen W.;Giordano, Frank J.;Carmeliet, Peter;Simons, Michael
通讯作者:
Simons, Michael